Immune-based therapies for prostate cancer.

Immune-based therapies for prostate cancer.

Item
http://www.wikidata.org/entity/Q35976724
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerFunctional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancerImmunotherapy and immune evasion in prostate cancer.A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapyImmunotherapy for prostate cancer: an emerging treatment modality.Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.Oncolytic virus-initiated protective immunity against prostate cancerEnhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer.DNA vaccines for prostate cancer.
P2860

Immune-based therapies for prostate cancer.

Item
http://www.wikidata.org/entity/Q35976724
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Immune-based therapies for prostate cancer.
@ast
Immune-based therapies for prostate cancer.
@en
type
label
Immune-based therapies for prostate cancer.
@ast
Immune-based therapies for prostate cancer.
@en
prefLabel
Immune-based therapies for prostate cancer.
@ast
Immune-based therapies for prostate cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Immune-based therapies for prostate cancer
@en
P2093
P304
P31
P356
10.1016/J.IMLET.2004.06.009
P433
P478
P50
P577
P5875
P698